D-Index & Metrics Best Publications

Louis M. Weiner

Georgetown University Medical Center
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 76 Citations 22,655 291 World Ranking 13886 National Ranking 7192

Research.com Recognitions

Awards & Achievements

2018 - Fellow, National Academy of Inventors

Overview

What is he best known for?

The fields of study Louis M. Weiner is best known for:

Cancer
Immune system
Antibody

Internal medicine and Carcinoma are frequently intertwined in his study. He integrates Carcinoma and Breast cancer in his studies. Louis M. Weiner performs integrative study on Breast cancer and Survival rate in his works. His multidisciplinary approach integrates Survival rate and Cancer in his work. Louis M. Weiner frequently studies issues relating to Cancer therapy and Cancer. Cancer therapy is frequently linked to Internal medicine in his study. With his scientific publications, his incorporates both Immune system and Cancer cell. Louis M. Weiner undertakes interdisciplinary study in the fields of Cancer cell and Immune system through his research. As part of his studies on Immunology, Louis M. Weiner often connects relevant subjects like CD3.

His most cited work include:

Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival (427 citations)
Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC (213 citations)
Monoclonal Antibodies in Cancer Therapy (209 citations)

What are the main themes of his work throughout his whole career to date

Louis M. Weiner is involved in relevant fields of research such as Perioperative and Chemoradiotherapy in the realm of Surgery. He connects Perioperative with Surgery in his study. His Internal medicine study often links to related topics such as Carcinoma. Many of his studies on Carcinoma involve topics that are commonly interrelated, such as Internal medicine. In his work, he performs multidisciplinary research in Immunology and Cytokine. He combines Immune system and Immunotherapy in his research. He combines Immunotherapy and Immune system in his research. He performs multidisciplinary study in Demography and Gerontology in his work. He conducts interdisciplinary study in the fields of Gerontology and Demography through his research.

Louis M. Weiner most often published in these fields:

Internal medicine (43.75%)
Immunology (37.50%)
Immune system (31.25%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Monoclonal antibody therapy of cancer

Gregory P Adams;Louis M Weiner.
Nature Biotechnology (2005)

1707 Citations

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

Martin A. Cheever;Martin A. Cheever;James P. Allison;Andrea S. Ferris;Olivera J. Finn.
Clinical Cancer Research (2009)

1376 Citations

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Louis M. Weiner;Rishi Surana;Shangzi Wang.
Nature Reviews Immunology (2010)

1334 Citations

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

Gregory P. Adams;Robert Schier;Adrian M. McCall;Heidi H. Simmons.
Cancer Research (2001)

854 Citations

Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding Site

Robert Schier;Adrian McCall;Gregory P. Adams;Keith W. Marshall.
Journal of Molecular Biology (1996)

587 Citations

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival

Adam C. Berger;Jeffrey Farma;Walter J. Scott;Gary Freedman.
Journal of Clinical Oncology (2005)

527 Citations

Isolation of high-affinity monomeric human anti-c-erbB-2 single chain Fv using affinity-driven selection.

Robert Schier;Jacqueline Bye;Gerald Apell;Adrian McCall.
Journal of Molecular Biology (1996)

500 Citations

Highly Specific in Vivo Tumor Targeting by Monovalent and Divalent Forms of 741F8 Anti-c-erbB-2 Single-Chain Fv

Gregory P. Adams;John E. McCartney;Mei-Sheng Tai;Hermann Oppermann.
Cancer Research (1993)

381 Citations

Increased Affinity Leads to Improved Selective Tumor Delivery of Single-Chain Fv Antibodies

Gregory P. Adams;Robert Schier;Keith Marshall;Ellen J. Wolf.
Cancer Research (1998)

376 Citations

Monoclonal antibody therapy for cancer.

Margaret von Mehren;Gregory P. Adams;Louis M. Weiner.
Annual Review of Medicine (2003)

369 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Louis M. Weiner